Long-Term Treatment of Collagenous Colitis With Budesonide

Long-Term Treatment of Collagenous Colitis With Budesonide. Prospective, Doubleblind Placebo-Controlled Trial.

The aim of the trial is to examine the effect of budesonide treatment on collagenous colitis. All patients is treated for 6 weeks with budesonide and thereafter randomised to 24 weeks treatment with placebo or continued budesonide. The end poit is effect on clinical symptoms (number of daily stools)

Inclusion Criteria:

• Histological criteria of Collagenous colitis
• Clinical activity (> 3 stools/day)

Exclusion Criteria:

• Treatment of Collagenous colitis within the last 3 months